Novo CEO pressed by Senate to cut price ranges of obesity, diabetic issues medications CEO Lars Fruergaard Jørgensen instructed lawmakers the business would consider new talks with insurers regarding the record price ranges of Wegovy and copyright if they pledge to keep the medicines on their formularies. This program aligns https://ayahealthcareaddress37271.uzblog.net/the-smart-trick-of-healthcare-news-that-nobody-is-discussing-44743878